Importantly, simultaneous treatment with TPL and THZ1 had a significantly more severe effect on TAM cells than on NT cells as well as either drug used independently, underscoring the potential of simultaneously inhibiting different TFIIH activities with TPL and THZ to develop alternative therapies for cancer treatment. The gene discussed is ERCC2; the disease is cancer.